Avid Radiopharmaceuticals Appoints Ernest Mario, Ph.D. to Board of Directors.Experienced pharmaceutical executive will help guide Avid expansion PHILADELPHIA -- Avid Radiopharmaceuticals, Inc., a leader in developing new molecular imaging agents for early detection of neurological disorders, today announced the addition of Ernest Mario, Ph.D. to its Board of Directors. Dr. Mario brings to Avid over 35 years of experience in the pharmaceutical, medical device and biotechnology fields and will provide his strategic expertise as Avid RP advances its clinical pipeline. Dr. Mario has provided senior level leadership to a number of top-tier pharmaceutical, biotechnology and medical device companies. He is currently Chairman of Reliant Pharmaceuticals, where he was also CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. from 2003 to 2006, and he serves on the boards of directors of Boston Scientific, Maxygen, Inc., Alexza Pharmaceuticals and Pharmaceutical Product Development, Inc. Previously Dr. Mario was Chairman and CEO of Apothogen, Inc. before it was acquired by IntraBiotics Pharmaceuticals, Inc. in 2002. He then held the position of Chairman of IntraBiotics until April 2003. From 1993 to 2001 Dr. Mario served as CEO of ALZA Corporation, and from 1989 to 1993 he served as CEO of Glaxo Holdings plc. Dr. Mario is a past Chairman of the American Foundation for Pharmaceutical Education and serves as an advisor to the pharmacy schools at the University of Maryland University of Maryland can refer to:
The University was first chartered as the state's agricultural school in 1888. The site of the school was originally the Oliver Watson Farm, and the original farmhouse still lies on the campus today. and The Ernest Mario School of Pharmacy Ernest Mario School of Pharmacy is a part of Rutgers University. The facilities are housed in William Levine Hall on Busch Campus in Piscataway, New Jersey. It was founded in 1892 as the Newark College of Pharmacy and then absorbed into Rutgers University in 1927 at Rutgers University. Dr. Mario holds a B.S. in Pharmacy from Rutgers, and an M.S. and a Ph.D. in Physical Sciences from the University of Rhode Island. He is the recipient of the 2007 Remington Medal, the highest honor the American Pharmacists Association The American Pharmacists Association (previously known as the American Pharmaceutical Association) is the first-established professional society of pharmacists within the United States and has over 60,000 members.[1] It was founded in 1852. bestows on a pharmacist in the United States. "I am looking forward to joining the Avid board. Avid's imaging programs hold great promise for improving the lives of patients and families affected by neurological disorders through advances in diagnosis and management of diseases such as Alzheimer's and Parkinson's," commented Dr. Mario. "Perhaps one of the most important challenges facing our health care system today is improving early detection and intervention in CNS See Continuous net settlement. CNS See continuous net settlement (CNS). diseases, and this will only continue to grow as our population ages. Avid has a chance to make a major impact in this area." "We are delighted to have someone with Dr. Mario's knowledge and experience joining our Board," said Daniel M. Skovronsky, M.D., Ph.D., CEO of Avid. "His expertise in guiding the successful growth of biotech and pharmaceutical companies will be invaluable to Avid as we move from development to commercialization of our molecular imaging compounds." About Avid Avid Radiopharmaceuticals, Inc. is developing novel diagnostic imaging agents to enable earlier and more accurate diagnosis, treatment selection and therapeutic monitoring of major medical disorders. The company is a pioneer in the development of molecular imaging agents for Alzheimer's disease and other neurological disorders and is developing products for imaging with both positron emission tomography positron emission tomography: see PET scan. positron emission tomography (PET) Imaging technique used in diagnosis and biomedical research. (PET) and single photon computed tomography (SPECT). The company has a collaboration in place with Bayer Schering Pharma AG Bayer Schering Pharma AG (FWB: SCH, NYSE: SHR) is a research-centered pharmaceutical company that was formed by the merger of Schering with Bayer on December 29 2006. The company was originally founded in 1851 by Ernst Schering (1824-1889). to develop its first PET molecular imaging agent for Alzheimer's disease. In addition, Avid is currently conducting clinical studies on a pipeline of next generation PET and SPECT agents. The company also has collaborative relationships with leading molecular imaging researchers at the University of Pennsylvania (body, education) University of Pennsylvania - The home of ENIAC and Machiavelli. http://upenn.edu/. Address: Philadelphia, PA, USA. and the University of Michigan (body, education) University of Michigan - A large cosmopolitan university in the Midwest USA. Over 50000 students are enrolled at the University of Michigan's three campuses. The students come from 50 states and over 100 foreign countries. . For more information, visit www.avidrp.com. |
|
|||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion